Colinz Labs

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE923C01011
  • NSEID:
  • BSEID: 531210
INR
42.00
0.00 (0.00%)
BSENSE

Dec 05

BSE+NSE Vol: 1.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -7.14% vs -1.75% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -8.79% vs -10.86% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 13.98% vs -28.87% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 2.03% vs 6.41% in Mar 2024

Compare Profit and Loss Results of Colinz Labs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6.00
11.00
-5.00
-45.45%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6.00
11.00
-5.00
-45.45%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
2.00
5.00
-3.00
-60.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
2.00
1.00
1.00
100.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
6.00
11.00
-5.00
-45.45%
Operating Profit (PBDIT) excl Other Income
0.00
0.00
0.00
0%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
0.00
0.00
0.00
0%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
0.00
0.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
1.00
1.00
100.00%
Profit Available for appropriations
3.00
2.00
1.00
50.00%
Appropriations
3.00
2.00
1.00
50.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.97
0.013
1.96
15,053.85%
Profit And Loss - Net Sales
Net Sales 6.53 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -7.14% vs -1.75% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -8.79% vs -10.86% in Mar 2024

Profit And Loss - Interest
Interest 0.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.98% vs -28.87% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.03% vs 6.41% in Mar 2024